Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.193
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.607
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.225
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.412
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
f:154m
|
|
|
NotProcessed |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:129m
|
|
|
NotProcessed |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00523
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0702
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.105
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.640
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0151
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.288
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, including Weight
|
3.74×10-05
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.151
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.674
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.863
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
1.79×10-05
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0992
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0688
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.500
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0358
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.0547
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.414
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.422
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.00651
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.633
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000142
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.175
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.205
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.926
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0415
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.257
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0107
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.579
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.158
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.449
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:129m
|
|
|
NotProcessed |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
f:154m
|
|
|
NotProcessed |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
6.15×10-06
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.129
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0422
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.741
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0872
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.210
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0220
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.563
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0960
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.748
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0513
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.974
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00153
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.445
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.443
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
1.70×10-05
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.794
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.798
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:30m
|
|
|
NotProcessed |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
35f:35m
|
|
|
NotProcessed |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00511
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0635
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.220
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
5f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.948
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0203
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.117
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0493
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.650
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.149
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.487
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
f:154m
|
|
|
NotProcessed |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:129m
|
|
|
NotProcessed |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0853
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.835
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.635
|
Successful |
Aff3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.943
|
Successful |